<PAGE>   1
                                                                   Exhibit 10.20


                 Warrant Agreement dated August 7, 1998 between
            Bionutrics, Inc., a Nevada corporation (the "Company"),
                      and William M. McCormick ("Holder")

                  Whereas Holder purchased $500,000 of the Company's Common
Stock (as defined in section 8.4) in February 1998 at $8 per share to assist the
Company in meeting urgent cash flow needs; and Whereas the Company, in
recognition of such investment and Holder's capital support of the Company, and
to encourage further investment, agreed to issue Holder the Warrants (as defined
below) to purchase shares of Common Stock;

                  Now therefore the parties agree as follows:

                  1.  Grant; Duration. The Company grants Holder warrants (the
"Warrants") to purchase up to 100,000 shares of Common Stock at the Exercise
Price (as defined in section 2), subject to adjustment as provided in Section 8,
during the period commencing on the date hereof and ending five years hereafter
(the "Exercise Period").

                  2.  Exercise Price. The Exercise Price for the Warrants is
$4.00 per share. 

                  3.  Warrant Certificates. The warrant certificates delivered
pursuant to this Warrant Agreement shall be in the form set forth in Exhibit A
with such appropriate changes required or permitted by this Agreement (the
"Warrant Certificates").

                  4.  Exercise of Warrant

                  4.1 Manner of Exercise. The Warrants are exercisable during
the Exercise Period (but not thereafter) at the Exercise Price and payable to
the Company at its executive offices located at 2425 E. Camelback Road (Suite
650), Phoenix, AZ 85016, attn: Chief Financial Officer (or such other officer as
designated to Holder by the Company by notice), by 
<PAGE>   2
certified or official bank check in New York Clearing House funds or wire
transfer. Upon surrender of a Warrant Certificate, submission of an executed
election to purchase or take cash on the appropriate form set forth in Exhibit B
and, if required, payment of the Exercise Price, Holder shall be entitled to
receive a certificate for the shares of Common Stock so purchased or cash as the
case may be. The purchase rights represented by each Warrant Certificate are
exercisable at the option of Holder, in whole or in part, but not as to
fractional shares of Common Stock.

                  4.2 Non-Cash Exercise; Cash in Lieu of Common Stock. Holder
shall have the right to exercise the Warrants, in full or in part, or (subject
to the second following sentence) by surrendering the Warrant Certificate to
receive cash in lieu of Common Stock. If Holder submits the non-cash election to
purchase, Holder shall be entitled to receive the number of shares of Common
Stock equal to the product of (x) the number of shares covered by the Warrants
being exercised multiplied by (y) a fraction, the numerator of which is the
closing price of the Company's Common Stock on the date of exercise less the
Exercise Price, and the denominator of which is such closing price. If Holder
submits an election to take cash in lieu of Common Stock, Holder shall be
entitled to receive a cash payment equal to the product of the number of the
Warrants being exercised times such closing price subject in the discretion of
the Company to its cash position and cash flow needs at such time. If the
Company so determines that it cannot make such cash payment, it shall so advise
Holder in which case Holder's election, if not withdrawn, shall be treated as a
non-cash election to purchase.



                                       2
<PAGE>   3
                  5.  Issuance of Certificates

                  5.1 Prompt Issuance. Upon exercise of the Warrants, the
certificates for the shares of Common Stock underlying the Warrants shall be
issued within ten business days without charge to the Holder including any tax
that may be payable in connection with the issuance, and such certificates shall
be issued in the name of, or in such name as may be directed by, Holder,
provided that the Company shall not be required to pay any tax payable solely
due to the issuance of a certificate in a name other than Holder. The Company
shall not be required to issue or deliver such certificates until Holder pays
the amount of such tax to the Company or establishes to the satisfaction of the
Company that such tax has been paid. Any cash payment due to Holder upon
exercise of the warrants shall be paid to Holder within ten business days
subject as aforesaid to the Company's cash position and cash flow needs at the
time.

                  5.2 Execution of Certificates. Stock certificates issued upon
exercise of the Warrants shall be executed by authorized officers of the
Company. The person in whose name any such stock certificate is issued shall for
all purposes be deemed to have become the holder of record of such shares on the
date of exercise of the Warrants.

                  5.3 New Warrant Certificate. If Holder purchases less than all
the shares of Common Stock purchasable under any Warrant Certificate, the
Company shall cancel the Warrant Certificate upon the surrender thereof and
shall execute and deliver a new Warrant Certificate of like tenor for the
balance of the shares of Common Stock not so purchased.

                  6. Transfer of Warrants. Subject to the restrictions set forth
in section 7, Holder may sell, assign, pledge, hypothecate or otherwise transfer
any rights under this Agreement following notice to the Company in the form of
Exhibit C.


                                       3
<PAGE>   4
                  7. Securities Act Transfer Restrictions. Neither the Warrants
nor the shares of Common Stock issuable upon exercise of the Warrants have been
registered under the Securities Act of 1933, as amended (the "Securities Act"),
or any applicable state securities or blue sky laws. Upon exercise of the
Warrants, the Company may cause a legend in substantially the form set forth
below to be placed on each certificate representing the shares of Common Stock
issued:

                  The securities represented by this certificate have not been
                  registered for public resale under the Securities Act of 1933,
                  as amended ("Securities Act"), and may not be offered,
                  transferred or sold except pursuant to (i) an effective
                  registration statement under the Securities Act and any
                  applicable state securities or blue sky laws, (ii) Rule 144
                  under the Securities Act (or any similar rule under the
                  Securities Act relating to the disposition of securities)
                  consistently with an opinion of counsel reasonably
                  satisfactory to issuer's counsel that such transfer is
                  permitted thereunder or (iii) section 4(2) of the Securities
                  Act consistently with an opinion of counsel reasonably
                  satisfactory to issuer's counsel that such exemption from
                  registration under the Securities Act and any applicable state
                  securities or blue sky laws is available.

                  8.  Adjustments to Exercise and Number of Securities

                  8.1 Recapitalization and Reclassifications. If upon a
recapitalization or reclassification the shares of Common Stock are changed into
or become exchangeable for a larger or smaller number of shares, upon the
effective date thereof the number of shares of Common Stock that Holder shall be
entitled to purchase upon exercise of the Warrants shall be increased or
decreased as the case may be in direct proportion to the increase or decrease in
the number of shares of Common Stock by reason of such recapitalization or
reclassification, and the Exercise Price in the case of an increase in the
number of shares shall be proportionately


                                       4
<PAGE>   5
decreased and, in the case of a decrease in the number of shares, shall be
proportionately increased.

              8.2 Sale; Merger; Consolidation. Subject to the prior notification
requirements of section 13, upon a transfer or sale of all or substantially all
the assets of the Company or, in the case of any consolidation or merger of the
Company with another entity (other than a consolidation or merger that does not
result in any reclassification or change of the outstanding Common Stock), the
transferee, purchaser or entity formed by or surviving a consolidation or
merger, as the case may be, shall execute and deliver to Holder a supplemental
warrant agreement giving Holder the right during the Exercise Period to receive
upon exercise of the Warrants the kind and amount of shares of stock and/or
other securities receivable upon such transfer, sale, consolidation or merger,
as the case may be, by a holder of the number of shares of Common Stock for
which the Warrants would have been exercisable immediately prior to such
transfer, sale, consolidation or merger provided that if such transfer, sale,
consolidation or merger results in the shareholders of the Company receiving
cash or publicly traded securities having a value per share in excess of the
Exercise Price, this Agreement shall terminate if not exercised prior to the
closing date of such transaction. Such supplemental warrant agreement shall
provide for adjustments identical to the adjustments provided in this section 8.

              8.3 Dividends and Other Distributions. If the Company declares a
dividend payable in shares of Common Stock, Holder shall be entitled to receive
upon exercise of the Warrants, in addition to the number of shares of Common
Stock covered by the exercise thereof, such additional shares of Common Stock as
Holder would have received had the Warrants been exercised immediately prior to
such record date for the dividend. If the Company declares a



                                       5
<PAGE>   6
dividend of securities other than a dividend of Common Stock, Holder shall
thereafter be entitled to receive, in addition to the shares of Common Stock
receivable upon the exercise of the Warrants, such non-Common Stock dividend as
Holder would have received had the Warrants been exercised immediately prior to
such record date for the dividend. At the time of any such dividend or
distribution, the Company shall make appropriate reserves to ensure the timely
performance of the provisions of this section 8.3. If the Company declares a
cash dividend the Holder shall not be entitled to receive any such dividend.

                  8.4 Definition of Common Stock. For the purpose of this
Agreement, the term Common Stock shall mean the following:

                           (a) the class of stock designated as Common Stock in
the articles of incorporation of the Company as may be amended, or any other
class of stock resulting from successive changes or reclassifications of the
Common Stock; and

                           (b) if, as a result of an adjustment made pursuant to
section 8, Holder shall upon exercise of the Warrants become entitled to receive
securities other than Common Stock, wherever appropriate all references herein
to Common Stock shall be deemed to refer to and include such other securities
and thereafter the number of such other securities shall be subject to
adjustment from time to time in a manner and upon terms as nearly equivalent as
practicable to the provisions of this section 8.

                  9. Issuance of New Warrant Certificate. Upon receipt by the
Company of evidence reasonably satisfactory to it of a loss, theft, destruction
or mutilation of a Warrant Certificate, reimbursement by Holder to the Company
of all incidental expenses and, in the case of loss, theft or destruction,
receipt of indemnity or security from Holder reasonably satisfactory


                                       6
<PAGE>   7
to it, or in the case of a mutilated Warrant Certificate upon surrender and
cancellation thereof, the Company shall make and deliver a replacement Warrant
Certificate to Holder.

                  10. Elimination of Fractional Interests. The Company shall not
be required to issue certificates representing fractions of shares of Common
Stock upon the exercise of the Warrants. The Company shall have the option to
make payment in cash in respect of any fractional shares or to round any
fraction up to the nearest whole number of shares of Common Stock.

                  11. Reservation and Listing of Securities. The Company shall
at all times reserve and keep available out of its authorized shares of Common
Stock, solely for the purpose of issuance upon the exercise of the Warrants,
such number of shares of Common Stock as shall be issuable upon the exercise
thereof. The Company covenants and agrees that, upon exercise of the Warrants
and payment of the Exercise Price by Holder, all shares of Common Stock issuable
upon such exercise shall be duly and validly issued, fully paid, non-assessable
and not subject to the preemptive rights of any stockholder. The Company shall
use its best efforts to cause all shares of Common Stock issuable upon the
exercise of the Warrants to be listed (subject to official notice of issuance)
on all securities exchanges on which the Common Stock may then be listed or
quoted.

                  12. Representations and Warranties of Holder. Holder
represents and warrants to the Company that the Warrants are being acquired
solely for Holder's own account, for investment, and not with a view to resale,
distribution, assignment, subdivision or fractionalization thereof, and Holder
has no present plans to enter into any contract, undertaking, agreement or
arrangement for any such purpose.


                                       7
<PAGE>   8
                  13. Notice to Warrant Holder. Nothing contained in this
Agreement shall be construed as conferring upon Holder, by virtue of holding the
Warrants, the right to vote, consent or receive notice as a stockholder in
respect of any meetings of stockholders for the election of directors or any
other matter, or as having any rights as a stockholder of the Company. If,
however, at any time prior to the expiration of the Warrants and their exercise,
any of the following events shall occur:

                  (a) the Company takes a record of the holders of its shares of
Common Stock for the purpose of entitling them to receive a dividend or
distribution payable otherwise than in cash, or a cash dividend or distribution
payable otherwise than out of current or retained earnings, as indicated by the
accounting treatment (which treatment shall be in accordance with generally
accepted accounting principles) of such dividend or distribution on the books of
the Company, or

                  (b) the Company offers to the holders of its Common Stock any
additional shares of capital stock of the Company or securities convertible into
or exchangeable for shares of capital stock of the Company, or any option, right
or warrant to subscribe therefor, or

                  (c) the Company proposes to a dissolve, liquidate, wind up,
transfer, consolidate, merge or sell all or substantially all its property,
assets and business as an entirety, it shall give notice of such event at least
15 days prior to the date fixed as a record date or the date of closing the
transfer books for the determination of the stockholders entitled to participate
in such event or entitled to vote thereon. Such notice shall specify such record
date or date of closing the transfer books as the case may be. Failure to
give such notice or any defect therein shall not affect the validity of any
action taken in connection with the declaration or payment of



                                       8
<PAGE>   9
any dividend, or the issuance of any convertible or exchangeable securities, or
subscription rights, options or warrants, or any proposed dissolution,
liquidation, winding up or sale.

                  14. Notices. Any notice or demand pursuant to this Agreement
shall be in writing and shall be deemed sufficiently given or made (a) upon
personal delivery, (b) the day following delivery to a recognized overnight
courier or (c) three days following mailing by certified or registered mail,
return receipt requested, postage prepaid, and addressed, until the other party
is notified of another address, as follows:

                  If to the Company:

                  Bionutrics, Inc.
                  2425 E. Camelback Road, Suite 650
                  Phoenix, AZ  85016
                  Attention of CFO

                  with a copy to:

                  J. Robert Horton
                  Friedman Siegelbaum (20th Floor)
                  399 Park Avenue
                  New York, NY  10022

                  If to Holder:

                  William M. McCormick
                  9 Pecksland Road
                  Greenwich, CT  06831

                  with a copy to:

                  John Aldrich
                  AYCO Company
                  Executive Woods 855 (Suite 120)
                  Rt. 146
                  Clifton Park, NY  12065

                  15. Miscellaneous


                                       9
<PAGE>   10
                  (a) Supplements and Amendments. This Agreement may be amended
or waived at any time but only by written agreement of the parties.

                  (b) Successors. All the covenants and provisions of this
Agreement shall be binding upon and inure to the benefit of the Company, Holder
and their respective successors and assigns hereunder.

                  (c) Governing Law; Submission to Jurisdiction. (i) This
Agreement and each Warrant Certificate issued hereunder shall be deemed to be a
contract made under the laws of Delaware without giving effect to rules
governing conflicts of law.

                  (ii) Any process or summons to be served upon either the
Company or Holder may be served in accordance with section 14. The prevailing
party in any such action or proceeding shall be entitled to recover from the
other party its reasonable legal costs and expenses incurred in connection
therewith.

                  (d) Entire Agreement; Modification. This Agreement contains
the entire understanding between the parties with respect to the subject matter
hereof and may not be modified or amended except by both parties.

                  (e) Severability. If any provision of this Agreement is held
to be invalid or unenforceable, such invalidity or unenforceability shall not
affect any other provision hereof.

                  (f) Captions. The caption headings of the sections of this
Agreement are for convenience of reference only, are not a part of this
Agreement and shall be given no substantive effect.



                                       10
<PAGE>   11
                  (g) Benefits of this Agreement. Nothing in this Agreement
shall be construed to give to any person or entity other than the Company and
Holder any legal or equitable right, remedy or claim hereunder.

                  (h) Counterparts. This Agreement may be executed in any number
of counterparts and each of such counterparts shall be deemed to be an original,
and such counterparts shall together constitute one instrument.

                  In witness whereof the parties have caused this Agreement to
be duly executed as of the date set forth in the heading.


                                Bionutrics, Inc.

                                By:  /s/ Ronald H. Lane
                                     -------------------------
                                     Ronald H. Lane
                                     Chief Executive Officer
                                   
                                     /s/ William M. McCormick        
                                     -------------------------
                                     William M. McCormick

                                       11
<PAGE>   12
                                                                       Exhibit A
                           Form of Warrant Certificate

THE WARRANTS REPRESENTED BY THIS CERTIFICATE AND THE SHARES OF STOCK ISSUABLE
UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE "SECURITIES ACT"), FOR PUBLIC RESALE AND MAY NOT BE OFFERED,
TRANSFERRED OR SOLD EXCEPT PURSUANT TO (i) AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS,
(ii) RULE 144 UNDER THE SECURITIES ACT (OR ANY SIMILAR RULE UNDER THE SECURITIES
ACT RELATING TO THE DISPOSITION OF SECURITIES) CONSISTENTLY WITH AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO ISSUER'S COUNSEL THAT SUCH TRANSFER IS
PERMITTED THEREUNDER OR (iii) SECTION 4(2) OF THE SECURITIES ACT CONSISTENTLY
WITH AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ISSUER'S COUNSEL THAT AN
EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT AND ANY APPLICABLE STATE
SECURITIES OR BLUE SKY LAWS IS AVAILABLE.

THE EXERCISE, TRANSFER AND EXCHANGE OF THE WARRANTS REPRESENTED BY THIS
CERTIFICATE ARE SUBJECT TO THE WARRANT AGREEMENT BETWEEN BIONUTRICS, INC. AND
WILLIAM M. MCCORMICK.

                                                      100,000 Warrants

                               Warrant Certificate

                  This Warrant Certificate certifies that William M. McCormick
("Holder") is the registered holder of 100,000 Warrants to purchase, at any time
from August 7, 1998, until 5:00 p.m. Eastern Standard Time on August 7, 2003
("Expiration Date"), up to 100,000 fully-paid and non-assessable shares of
common stock, par value $.001 per share ("Common Stock"), of Bionutrics, Inc., a
Nevada corporation (the "Company"), at an exercise price determined pursuant to
section 2 of the Warrant Agreement dated August 7, 1998, between Holder and the
Company (the "Agreement"), upon surrender of this Warrant Certificate and
payment of such exercise price to the Company and subject to the Agreement.

                  At 5:01 p.m. Eastern Standard Time on the Expiration Date the
Warrants evidenced hereby, unless exercised prior thereto, shall be void.



                                      A-1
<PAGE>   13
                  The Agreement is incorporated by reference and made a part of
this Warrant Certificate and is referred to for a description of the rights,
obligations, duties and restrictions of the Holder and the Company relating to
the Warrants including the option of Holder to make a non-cash election to
purchase Common Stock election to take cash in lieu of Common Stock. 

                  In witness whereof the Company has caused this Warrant
Certificate to be duly executed on this 7th day of August 1998.

                                 Bionutrics, Inc.

                                 By:  /s/ Ronald H. Lane
                                      -----------------------
                                      Ronald H. Lane
                                      Chief Executive Officer


                                      A-2
<PAGE>   14
                                                                       Exhibit B
                        Form of Cash Election to Purchase

         The undersigned hereby irrevocably elects to exercise the right
represented by the attached Warrant Certificate to purchase shares of common
stock, par value $.001, of Bionutrics, Inc. at an exercise price of $_______ per
share and herewith tenders in payment for such stock [a certified or official
bank check] [confirmation of wire transfer] payable in New York Clearing House
Funds, in the amount of $_________ to the order of Bionutrics, Inc. The
undersigned requests that the certificate for such securities be registered in
the name of _______ and delivered to whose address is ________________________.

Date:__________               --------------------
                              William M. McCormick


                      Form of Non-Cash Election to Purchase

         The undersigned hereby irrevocably elects to exercise the right
represented by the attached Warrant Certificate to purchase ________ shares of
common stock, par value $.001, of Bionutrics, Inc. at an exercise price of $
per share and herewith tenders to Bionutrics, Inc. in payment for such stock
such number of Warrants (________) calculated pursuant to section 4.2 of the
related warrant agreement. The undersigned requests that the certificates for
such newly purchased securities be registered in the name of ____ and delivered
to whose address is _________________________________.

Date:__________                --------------------
                               William M. McCormick


              Form of Election to Take Cash in Lieu of Common Stock

         Subject in the discretion of the Company to its cash position and cash
flow needs at the time the undersigned hereby irrevocably elects to exercise the
right represented by the attached Warrant Certificate to take a cash payment
equal to ______, that is, the number the shares of common stock,  par  
value $.001 per share, Holder would have received upon a non-cash election to
purchase ________ shares times the closing price of $___________ per share,
and herewith tenders to Bionutrics, Inc., in return for such cash payment such
number of Warrants (________) calculated pursuant to section 4.2 of the related
warrant agreement. The undersigned requests that the cash payment be sent as
follows:__________________________________________.

Date:__________               --------------------
                              William M. McCormick


                                       B-1
<PAGE>   15
                                                                       Exhibit C

                               Form of Assignment

   For value received the undersigned hereby sells, assigns and transfers unto

                    ______________________________________________________

                    ______________________________________________________

                    ______________________________________________________



this Warrant Certificate, together with all right, title and interest therein.

Date: _________________    
                                                  ___________________________

                                      C-1